179 related articles for article (PubMed ID: 29909719)
1. Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis.
Dolan SB; Shetty RA; Forster MJ; Gatch MB
J Psychopharmacol; 2018 Jul; 32(7):802-810. PubMed ID: 29909719
[TBL] [Abstract][Full Text] [Related]
2. Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.
Gatch MB; Dolan SB; Forster MJ
Drug Alcohol Depend; 2019 Jun; 199():50-58. PubMed ID: 30986635
[TBL] [Abstract][Full Text] [Related]
3. Effect of N-Benzylpiperazine, Its Metabolite N-Benzylethylenediamine, and Its Disubstituted Analogue N,N'-Dibenzylpiperazine on the Acquisition, Formation, and Consolidation of Memory in Mice.
Castillo-Hernández JC; Velázquez-Moyado JA; Reyes-Ramírez A; Ramírez-López EG; González-Andrade M; Navarrete A
Pharmacology; 2017; 99(5-6):268-274. PubMed ID: 28219076
[TBL] [Abstract][Full Text] [Related]
4. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
[TBL] [Abstract][Full Text] [Related]
5. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
[TBL] [Abstract][Full Text] [Related]
6. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
Yarosh HL; Katz EB; Coop A; Fantegrossi WE
Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
[TBL] [Abstract][Full Text] [Related]
7. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
Fantegrossi WE; Winger G; Woods JH; Woolverton WL; Coop A
Drug Alcohol Depend; 2005 Feb; 77(2):161-8. PubMed ID: 15664717
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
Dolan SB; Forster MJ; Gatch MB
Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
[TBL] [Abstract][Full Text] [Related]
9. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
[TBL] [Abstract][Full Text] [Related]
10. Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.
Gatch MB; Dolan SB; Forster MJ
Psychopharmacology (Berl); 2017 Apr; 234(8):1237-1245. PubMed ID: 28210779
[TBL] [Abstract][Full Text] [Related]
11. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
12. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.
Saber I; Milewski A; Reitz AB; Rawls SM; Walker EA
Psychopharmacology (Berl); 2019 Mar; 236(3):1015-1029. PubMed ID: 30980094
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of four novel synthetic cathinone analogs in rodents.
Gatch MB; Shetty RA; Sumien N; Forster MJ
Addict Biol; 2021 Jul; 26(4):e12987. PubMed ID: 33155384
[TBL] [Abstract][Full Text] [Related]
14. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
15. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
Dickson AJ; Vorce SP; Holler JM; Lyons TP
J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
[TBL] [Abstract][Full Text] [Related]
17. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
[TBL] [Abstract][Full Text] [Related]
18. Benzylpiperazine: a drug of abuse?
Johnstone AC; Lea RA; Brennan KA; Schenk S; Kennedy MA; Fitzmaurice PS
J Psychopharmacol; 2007 Nov; 21(8):888-94. PubMed ID: 17606471
[TBL] [Abstract][Full Text] [Related]
19. Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants.
Shetty RA; Hoch AC; Sumien N; Forster MJ; Gatch MB
J Psychopharmacol; 2023 May; 37(5):520-528. PubMed ID: 36738095
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic effects and their action mechanism of the major active components of party pill drugs.
Min CR; Kim MJ; Park YJ; Kim HR; Lee SY; Chung KH; Oh SM
Toxicol Lett; 2012 Nov; 214(3):339-47. PubMed ID: 23026265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]